Q5ZZS2 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicwnnluzofi4u5h2yatlc76s4jrlqvzrkybgcjykktcza5cfsicqa/metadata.json
IPFS of structure file: 
bafybeiffzesihgawvbeqs6rnxmcqytrdv2cjrswypc5l6tksfp4sou6yhy/AF-Q5ZZS2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x738c1929c69B751bD0Be0B962D9bac20B631aAc6
First NFT owner address (bech32): 
genesis1wwxpj2wxnd63h597pwtzmxavyzmrr2kx0xhph5
Current NFT ID #388498 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388498
Accession (UniProt):
Q5ZZS2
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma hyopneumoniae (strain 232)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q5ZZS2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q5ZZS2|RPOC_MYCH2 DNA-directed RNA polymerase subunit beta' OS=Mycoplasma hyopneumoniae (strain 232) OX=295358 GN=rpoC PE=3 SV=1 MNTKVSRQYAKISENSIQKISLALATPEDVLEWSRGEVHRPETINYKTFKPERGGLFDELIFGPLVDYKCSVCGRKYRKSNENQLCIATKECKIRGSRILSKMARRYSMGHIALNAPILHFWFFKIDHSIIAKLLGLKVFEGNSKVPTTITKTAIENLIYYKSHIVLETGGLKSLEQNKIIDISEAGLIYKNALIEIIEFYPPGSEEHNALAESISELADVTSSKIGREYGVDYYELNEIIEEFSSARIATGALAIEYLLDKIDLRAEKAAVEAELAGVQKQIYKNKKIILKNQKRDKLYKRLQVINAFINSGQDPKMMIIRNLPVIPADLRPLVQLDGSRHSTSDCNELYRRIIIRNNRLKRWKAAHAPVIIIQNEMRMLQEAVDALIDNQKKSTNQVTTKEGRPLKSISDALTGKKGRFRQNLLGKRVDYSGRSVIVVGPKLKMHQAGLPRKMAAVLFEPWIIRNLIQEKKVGSIKMARKMIEEENPIIWPHVAKVIQNKPIILNRAPTLHRLSIQAFEPVLVRAKAIQLHPLVTAGFNADFDGDQMAVHIPISPEAIRETQELMFADKNILGPKDGEPIVNPSQDMVLGLYYLSQEKAGAKGEGSFFSTYEAMLKAYEFRSVELHARVVLPFEQVKPFIAKTMRGHLISTVGKFILNNIFPANFPFIFDDNVDELELNYPSQIKKYVLPYGTNFREYIQNLKVNEPLNKKAIAKIVRQIFDTYDGLLAKEDIATVIDQLDFGNYQNRVLLYEKLRDYKKQKLPVPHLSKLSEFTIFEYSQLYKQLQQNGPVESYRVLEDHEKAELLEKIWFKYNNMVCSILDKIKDLGFHYSTLSGTSIAISDIKMAPKKHEFIKDGENYINKLNTFYAKGLITDDERYVLAIAKWTQIKNDIQEDLNQSIKDDNQNSLVMMMKSGARGNISNFVQLAGMRGLMANNVKALKVDAENERVVRSIVEVPVKSSFLEGLTSFEFYSSTHGARKGLTDTALNTAKSGYLTRRLVDVAQNIVVVAEDCFSDFGFVVKDIIDTKTNTIIVPLLERIEGRFLNKDVYDSRGIKLASAGSMVDLQTAKKIVAAGIKKVEIRSILSCHIKNSVCKKCYGKDLATNRLVSIGEAVGIIAAQSIGEPGTQLTMRTFHTGGVANVEDITGGFTRLIELIDSHEHPWGKPAKISPYYGIITKISDLAEKNAANKGFLITIEYKTSKNEKAEHIIRIEQSQKLRVKVGDKVIPGQKLVEGPIILKELLAVSDARTLQNYLLKEIQRIYRMQGISISDKYIEIIIRQMLSKVQIIENGDSNFFIGSIVDISDYQEVNGQLISQNKNPAFGNVIVKGAKQIPLLSNSFLAAASYQETSKILVHSVISSQIDKLEGLKENIIVGHKIPAGTNSNYEPKSKFDIRNPLSFFMKNNR